To include your compound in the COVID-19 Resource Center, submit it here.

BMS-790052: Interim Phase IIa data

Interim data from the ongoing, open-label, international Phase IIa AI447011 trial in patients with HCV genotype 1 infection who

Read the full 197 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE